CTC trials at the 18th British Thoracic Oncology Group (BTOG) conference 2020
31 January 2020
The British Thoracic Oncology Group (BTOG) conference took place in Dublin this month, with a number of studies coordinated by the CR UK & UCL CTC involved. 

The SUMMIT study had 4 poster presentations. These exhibited early data in the management of pulmonary nodules, extrapulmonary incidental findings and pulmonary findings, as well as data highlighting the invitation strategy of this important lung cancer CT screening study. 

The EARL study, examining electrocautery ablation for the prevention of lung cancer, had a poster presentation and also an oral presentation in which Dr Lukas Kalinke presented the trial endpoints, inclusion criteria, recruitment strategy, and details on the investigational electrocautery treatment (see photo).

The SARON study, looking at stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer, had a poster presentation highlighting the recent changes in trial design to allow patients who would usually receive immunotherapy to take part in the trial. Dr Fiona McDonald relaunched the trial at BTOG and presented the changes to investigators in attendance. 

We would also like to congratulate Dr Sophie Tisi, who was the runner up at the conference’s best poster presentation category for her SUMMIT study poster.


Image: Dr Lukas Kalinke presents EARL at the BTOG conference
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map
Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2022 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us